Table 2.
Participant demographics.
| Patient demographics | Population, n = 13 |
|---|---|
| Age/years | 41.7 (11.8) |
| Mean (standard deviation, SD) | |
| Average time since initial COVID positivity/months | 14.7 (5.8) |
| Mean (standard deviation, SD) | |
| Gender | |
| Female n (%) | 7 (53.8) |
| Male n (%) | 6 (46.2) |
| Ethnicity | |
| White n (%) | 12 (92.3) |
| Mixed race n (%) | 1 (7.7) |
| Symptoms | |
| Fatigue n (%) | 10 (76.9) |
| Breathlessness n (%) | 8 (61.5) |
| Medication history | |
| Tricyclic antidepressants n (%) | 2 (15.9) |
| SSRI/ n (%) | 2 (15.9) |
| Codene/ibuprofen n (%) | 3 (23.1) |
| Ivabridine/bisoprolol n (%) | 3 (23.1) |
| Past medical history | |
| Anxiety/depression n (%) | 3 (23.1) |
| Atopy n (%) | 4 (30.8) |